SCHEMBL267487

SCHEMBL267487

Cc1ccc(C=NNC(=O)c2cc3ccccc3cc2NC(=O)c2cccc(CN3CCN(CCO)CC3)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.43
GAA P10253 2/20 0.43
MGAM O43451 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
POLB P06746 3/20 0.43
MAPT P10636 4/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
HTT P42858 3/20 0.42
HPGD P15428 1/20 0.42
L3MBTL1 Q9Y468 4/20 0.42
ALDH1A1 P00352 3/20 0.42
PKM P14618 3/20 0.40
RECQL P46063 1/20 0.40
BLM P54132 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL267486 1.00 ACHE (0.43) ACHEGAAMGAMSIMGAM2
SCHEMBL267541 0.92 ACHE (0.52) ACHEGAAMGAMSIMGAM2
SCHEMBL266896 0.92 MEN1 (0.42) ACHEGAAMEN1KMT2ARAB9A
SCHEMBL266895 0.92 MEN1 (0.42) ACHEGAAMEN1KMT2ARAB9A
SCHEMBL267540 0.92 ACHE (0.52) ACHEGAAMGAMSIMGAM2
SCHEMBL267619 0.88 SLC34A2 (0.50) GAAMGAMSIMGAM2MEN1
SCHEMBL267618 0.88 SLC34A2 (0.50) GAAMGAMSIMGAM2MEN1
SCHEMBL269363 0.87 NPC1 (0.43) ACHEMEN1KMT2ARAB9ANPC1
SCHEMBL269362 0.87 NPC1 (0.43) ACHEMEN1KMT2ARAB9ANPC1
SCHEMBL268340 0.86 MAPT (0.43) MEN1KMT2ARAB9ANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115851-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-05-10 US disclosed
US-8134015-B2 Compound inhibiting in vivo phosphorous transport and medicine containing the same KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-03-13 US disclosed
US-20060217426-A1 Compound inhibiting in vivo phosphorous transport and medicine containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-28 US disclosed
EP-1614676-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2006-01-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217426-A1 Compound inhibiting in vivo phosphorous transport and medicine containing the same SLC10A6, SLC7A1, SLC10A1 ACHE 4048/4885GAA 1336/4885MGAM 3559/4885
US-20120115851-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME SLC34A1, SLC34A2, SLC20A2 ACHE 3423/4885GAA 1640/4885MGAM 3483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.